Hosted on MSN
MindRank in phase 3 trial with China’s first AI-assisted new drug, cutting R&D costs by 60%
The company was aiming for approval in the second half of 2028, paving the way for a market launch in 2029 Hangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its ...
Shandong Provincial Key Laboratory of Digital Medicine and Computer-Assisted Surgery has the following research output in the current window (1 January 2025 - 31 December 2025) of the Nature Index.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results